Related Experiment Videos

Autosomal recessive polycystic kidney disease in a murine model. A gross and microscopic description

V H Gattone1, J P Calvet, B D Cowley

  • 1Department of Anatomy, University of Kansas Medical Center, Kansas City.

Insights

Autosomal recessive polycystic kidney disease in C57BL/6J-cpk mice shows two phases: early proximal tubule changes and later collecting duct cysts. Cell proliferation is minimal, suggesting other mechanisms drive kidney enlargement.

Area of Science:

  • Nephrology
  • Genetics
  • Developmental Biology

Background:

  • Autosomal recessive polycystic kidney disease (ARPKD) is a genetic disorder.
  • The C57BL/6J-cpk mouse is a model for studying ARPKD pathogenesis.
  • Understanding ARPKD mechanisms is crucial for potential therapeutic targets.

Purpose of the Study:

  • To investigate the pathogenesis of renal cystic disease in the C57BL/6J-cpk murine model.
  • To characterize the morphological and growth changes associated with ARPKD.
  • To identify the cellular mechanisms underlying kidney enlargement in ARPKD.

Main Methods:

  • Utilized C57BL/6J-cpk mice from fetal to 3-week-old stages.
  • Employed light and electron microscopy for kidney morphology.
  • Performed nephron segment microdissection.
  • Assessed cell proliferation using mitotic index and Histone H4 gene expression.

Main Results:

  • Identified two distinct phases of cystic disease development.
  • Phase 1 (fetal/newborn): Proximal tubule enlargement, increased mitotic index, and cell necrosis.
  • Phase 2 (1-3 weeks): Kidney enlargement due to collecting duct cysts, azotemia, and stunted growth. Minimal increase in cell proliferation markers observed.

Conclusions:

  • ARPKD pathogenesis involves distinct early and late phases.
  • Collecting duct cystic changes are primary drivers of kidney enlargement in later stages.
  • The observed tubular enlargement occurs with minimal contribution from significant cell proliferation.

Related Concept Videos